U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07386496) titled 'The Role of 18F-PSMA PET in Prostate Cancer Diagnosis in Equivocal MRI' on Jan. 20.
Brief Summary: This study is a multi-center RCT to compare the clinically significant prostate cancer (csPCa) detection and/or change in clinical management in MRI guided (MRI arm) biopsy and MRI+18F-PSMA guided (Combined arm) biopsies in men with equivocal MRI prostate scans. If additional clinical value is shown by adding 18F-PSMA PET to equivocal MRI, then this should be the new standard of care.
Study Start Date: March 01
Study Type: INTERVENTIONAL
Condition:
Prostate Cancer
Intervention:
PROCEDURE: MRI+PSMA-guided approach
MRI+PSMA-guided ...